XML 110 R181.htm IDEA: XBRL DOCUMENT v2.4.0.8
Schedule II - Condensed Financial Information of Registrant - Condensed Statements of Cash Flows of Registrant (Details) (USD $)
12 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2012
Cash flows from operating activities:      
Net income (loss) $ 101,700,000 $ (69,000,000) $ 110,700,000
Adjustments to reconcile net income (loss) to operating cash flows:      
Depreciation and amortization 302,600,000 358,700,000 268,300,000
Stock compensation 91,100,000 61,500,000 31,200,000
Amortization of debt issuance costs 21,000,000 18,100,000 12,800,000
Amortization of debt discount 4,600,000 3,000,000 1,300,000
Write-off of debt issuance costs on retired debt 6,400,000 32,400,000 2,900,000
Write-off of debt discount on retired debt 2,800,000 (3,100,000) (500,000)
Equity in net income of subsidiaries       
Gain On Contingent Purchase Price Adjustment (500,000)    (41,000,000)
Changes in operating assets and liabilities:      
Net change in cash due to operating activities 607,900,000 522,300,000 622,500,000
Cash flows from investing activities:      
Proceeds from investments sold, matured or repaid 5,609,200,000 9,432,200,000 6,206,700,000
Cost of investments acquired (7,221,400,000) (8,940,800,000) (5,972,700,000)
Capital expenditures (98,200,000) (100,100,000) (53,500,000)
Net change in cash due to investing activities (1,920,600,000) (2,010,800,000) (185,600,000)
Cash flows from financing activities:      
Dividends paid on preferred stock (28,600,000) (33,400,000) (23,600,000)
Repayment of senior secured notes, including tender / call premium     0
Common stock repurchased (65,600,000) (12,300,000)  
Share based award tax withholding payments (31,500,000) (22,300,000) (3,900,000)
Other financing activities, net 2,800,000    (1,000,000)
Net change in cash due to financing activities 740,400,000 1,922,000,000 (102,700,000)
Net change in cash and cash equivalents (580,500,000) 429,000,000 333,300,000
Cash and cash equivalents at beginning of period 1,899,700,000 1,470,700,000 1,137,400,000
Cash and cash equivalents at end of period 1,319,200,000 1,899,700,000 1,470,700,000
HGI
     
Cash flows from operating activities:      
Net income (loss) (10,300,000) (45,800,000) 89,500,000
Adjustments to reconcile net income (loss) to operating cash flows:      
Depreciation and amortization 200,000 200,000 100,000
Stock compensation 27,000,000 11,700,000 1,900,000
Amortization of debt issuance costs 3,500,000 2,700,000 2,900,000
Amortization of debt discount 1,500,000 500,000 600,000
Write-off of debt issuance costs on retired debt 0 10,800,000 0
Write-off of debt discount on retired debt 0 2,100,000 0
Deferred income taxes 0 0 3,600,000
Equity in net income of subsidiaries (207,700,000) (263,700,000) (354,600,000)
Dividends from subsidiaries 118,000,000 127,100,000 69,500,000
Loss from the change in the fair value of the equity conversion feature of preferred stock 12,700,000 101,600,000 156,600,000
Gain On Contingent Purchase Price Adjustment (500,000)    
Changes in operating assets and liabilities:      
Prepaid expenses and other current assets 0 0 (4,600,000)
Accounts payable and accrued and other current liabilities 43,500,000 51,400,000 27,000,000
Other operating (700,000) 11,600,000 (1,700,000)
Net change in cash due to operating activities (12,800,000) 10,200,000 (9,200,000)
Cash flows from investing activities:      
Proceeds from investments sold, matured or repaid 0 34,000,000 108,900,000
Cost of investments acquired 0 0 (68,000,000)
Capital contributions to consolidated subsidiaries (115,500,000) (454,400,000) (36,300,000)
Return of capital from subsidiary 0 126,800,000 88,000,000
(Advances to) repayments from consolidated subsidiaries 0 0 49,300,000
Capital expenditures (300,000) (400,000) 0
Net change in cash due to investing activities (115,800,000) (294,000,000) 141,900,000
Cash flows from financing activities:      
Dividends paid on preferred stock (28,600,000) (33,400,000) (31,700,000)
Proceeds from senior secured notes 400,000,000 923,900,000 0
Repayment of senior secured notes, including tender / call premium 0 (545,900,000)  
Debt issuance costs (10,400,000) (25,100,000) 0
Common stock repurchased (65,600,000) (12,300,000)  
Share based award tax withholding payments (6,500,000) (2,300,000)  
Other financing activities, net 2,800,000 0 0
Net change in cash due to financing activities 291,700,000 304,900,000 (31,700,000)
Net change in cash and cash equivalents 163,100,000 21,100,000 101,000,000
Cash and cash equivalents at beginning of period 256,900,000 235,800,000 134,800,000
Cash and cash equivalents at end of period $ 420,000,000 $ 256,900,000 $ 235,800,000